Treatment of acute intracerebral hemorrhage


Opinion statement

Intracerebral hemorrhage (ICH) is a neurologic emergency associated with regular, early, ongoing hemorrhage, progressive clinical deterioration, severe deficits, and high mortality. Hence, it requires prompt recognition, diagnosis, and management. Initial monitoring and management of patients with ICH should occur in an intensive care unit. The overall approach to treatment mandates using therapies to stop or slow the initial bleeding acutely, removing blood from the parenchyma or ventricles (in eligible patients) to prevent secondary brain injury, addressing raised intracranial pressure, and providing good, comprehensive supportive care, including management of airways, oxygenation, blood pressure, circulation, glucose level, fever, and nutrition, as well as deep venous thrombosis prophylaxis.

References and Recommended Reading

  1. 1.
    Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD: Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989–90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994, 57:936–940.PubMedCrossRefGoogle Scholar
  2. 2.
    Broderick JP, Brott T, Tomsick T, et al.: Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993, 78:188–191.PubMedGoogle Scholar
  3. 3.
    Counsell C, Boonyakarnkul S, Dennis M, et al.: Primary intracerebral haemorrhage in the Oxfordshire Community Stroke project, 2: prognosis. Cerebrovasc Dis 1995, 5:26–34.CrossRefGoogle Scholar
  4. 4.
    Flaherty ML, Woo D, Haverbusch M, et al.: Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005, 36:934–937.PubMedCrossRefGoogle Scholar
  5. 5.
    Flaherty ML, Haverbusch M, Sekar P, et al.: Long-term mortality after intracerebral hemorrhage. Neurology 2006, 66:1182–1186.PubMedCrossRefGoogle Scholar
  6. 6.
    Goldstein LB, Simel DL: Is this patient having a stroke? JAMA 2005, 293:2391–2402.PubMedCrossRefGoogle Scholar
  7. 7.
    Broderick J, Connolly S, Feldmann E, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007, 38:2001–2023.PubMedCrossRefGoogle Scholar
  8. 8.
    Aguilar MI, Demaerschalk BM: Intracerebral hemorrhage. Semin Neurol 2007, 27:376–384.PubMedCrossRefGoogle Scholar
  9. 9.
    Freeman WD, Brott TG: Modern treatment options for intracerebral hemorrhage. Curr Treat Options Neurol 2006, 8:145–157.PubMedCrossRefGoogle Scholar
  10. 10.
    Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF: Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc 2005, 80:420–433.PubMedGoogle Scholar
  11. 11.
    Goldstein LB, Adams R, Alberts MJ, et al.: Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group, Cardiovascular Nursing Council, Clinical Cardiology Council, Nutrition, Physical Activity, and Metabolism Council, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke 2006, 37:1583–1633. (Published erratum appears in Stroke 2007, 38:207.)PubMedGoogle Scholar
  12. 12.
    Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785.PubMedCrossRefGoogle Scholar
  13. 13.
    Mayer SA, Brun NC, Begtrup K, et al.: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127–2137.PubMedCrossRefGoogle Scholar
  14. 14.
    Brody DL, Aiyagari V, Shackleford AM, Diringer MN: Use of recombinant factor VIIa in patients with warfarinassociated intracranial hemorrhage. Neurocrit Care 2005, 2:263–267.PubMedCrossRefGoogle Scholar
  15. 15.
    Flaherty ML, Kissela B, Woo D, et al.: The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007, 68:116–121.PubMedCrossRefGoogle Scholar
  16. 16.
    Aguilar MI, Hart RG, Kase CS, et al.: Treatment of warfarinassociated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007, 82:82–92.PubMedGoogle Scholar
  17. 17.
    Levine JM, Snider R, Finkelstein D, et al.: Early edema in warfarin-related intracerebral hemorrhage. Neurocrit Care 2007, 7:58–63.PubMedCrossRefGoogle Scholar
  18. 18.
    Xi G, Keep RF, Hoff JT: Pathophysiology of brain edema formation. Neurosurg Clin North Am 2002, 13:371–383.CrossRefGoogle Scholar
  19. 19.
    Sjoblom L, Hardemark HG, Lindgren A, et al.: Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 2001, 32:2567–2574.PubMedCrossRefGoogle Scholar
  20. 20.
    Berwaerts J, Robb OJ, Jeffers TA, Webster J: Intracerebral haemorrhages and oral anticoagulation in the north of Scotland. Scott Med J 2000, 45:101–104.PubMedGoogle Scholar
  21. 21.
    Flibotte JJ, Hagan N, O’Donnell J, et al.: Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004, 63:1059–1064.PubMedGoogle Scholar
  22. 22.
    Yasaka M, Minematsu K, Naritomi H, et al.: Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 2003, 89:278–283.PubMedGoogle Scholar
  23. 23.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587.CrossRefGoogle Scholar
  24. 24.
    Derex L, Hermier M, Adeleine P, et al.: Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005, 76:70–75.PubMedCrossRefGoogle Scholar
  25. 25.
    Demchuk AM, Morgenstern LB, Krieger DW, et al.: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34–39.PubMedGoogle Scholar
  26. 26.
    Mahaffey KW, Granger CB, Sloan MA, et al.: Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation 1998, 97:757–764.PubMedGoogle Scholar
  27. 27.
    Warach S, Latour LL: Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004, 35:2659–2661.PubMedCrossRefGoogle Scholar
  28. 28.
    Gebel JM, Brott TG, Sila CA, et al.: Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke 2000, 31:596–600.PubMedGoogle Scholar
  29. 29.
    Mahaffey KW, Granger CB, Sloan MA, et al.: Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue-plasminogen activator (tPA) for Occluded coronary arteries. Am Heart J 1999, 138:493–499.PubMedCrossRefGoogle Scholar
  30. 30.
    Misra UK, Kalita J, Ranjan P, Mandal SK: Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci 2005, 234:41–45.PubMedCrossRefGoogle Scholar
  31. 31.
    Cruz J, Minoja G, Okuchi K: Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery 2002, 51:628–637; discussion 637–628.PubMedCrossRefGoogle Scholar
  32. 32.
    Freeman WD, Brott TG, Barrett KM, et al.: Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004, 79:1495–1500.PubMedCrossRefGoogle Scholar
  33. 33.
    Suarez JI, Qureshi AI, Bhardwaj A, et al.: Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998, 26:1118–1122.PubMedCrossRefGoogle Scholar
  34. 34.
    Steiner T, Diringer MN, Schneider D, et al.: Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006, 59:767–773; discussion 773–774.PubMedCrossRefGoogle Scholar
  35. 35.
    Sugg RM, Gonzales NR, Matherne DE, et al.: Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2006, 67:1053–1055.PubMedCrossRefGoogle Scholar
  36. 36.
    Fernandes HM, Gregson B, Siddique S, Mendelow AD: Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 2000, 31:2511–2516.PubMedGoogle Scholar
  37. 37.
    Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387–397.PubMedGoogle Scholar
  38. 38.
    STICH II Trial. Accessed August 18, 2008.
  39. 39.
    Morioka J, Fujii M, Kato S, et al.: Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg Neurol 2006, 65:67–72; discussion 72–73.PubMedCrossRefGoogle Scholar
  40. 40.
    Da Pian R, Bazzan A, Pasqualin A: Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res 1984, 6:145–151.PubMedGoogle Scholar
  41. 41.
    Firsching R, Huber M, Frowein RA: Cerebellar haemorrhage: management and prognosis. Neurosurg Rev 1991, 14:191–194.PubMedCrossRefGoogle Scholar
  42. 42.
    van Loon J, Van Calenbergh F, Goffin J, Plets C: Controversies in the management of spontaneous cerebellar haemorrhage. A consecutive series of 49 cases and review of the literature. Acta Neurochir (Wien) 1993, 122:187–193.CrossRefGoogle Scholar
  43. 43.
    Nishihara T, Nagata K, Tanaka S, et al.: Newly developed endoscopic instruments for the removal of intracerebral hematoma. Neurocrit Care 2005, 2:67–74.PubMedCrossRefGoogle Scholar
  44. 44.
    Vespa P, McArthur D, Miller C, et al.: Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care 2005, 2:274–281.PubMedCrossRefGoogle Scholar
  45. 45.
    Murthy JM, Chowdary GV, Murthy TV, et al.: Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage. Neurocrit Care 2005, 2:258–262.PubMedCrossRefGoogle Scholar
  46. 46.
    Hanley D, Hacke W: Critical care and emergency medicine neurology in stroke. Stroke 2005, 36:205–207.PubMedCrossRefGoogle Scholar
  47. 47.
    Demaerschalk BM: Fibrinolytic therapy for intraventricular hemorrhage: is the answer becoming clear yet? Eur J Neurol 2008, 15:320–322.PubMedCrossRefGoogle Scholar
  48. 48.
    Powner DJ, Hartwell EA, Hoots WK: Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 2005, 57:823–831.PubMedCrossRefGoogle Scholar
  49. 49.
    Teernstra OP, Evers SM, Lodder J, et al.: Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 2003, 34:968–974.PubMedCrossRefGoogle Scholar
  50. 50.
    CLEAR-IVH Trial: Thrombolytic Brain Hemorrhage Study. Accessed August 18, 2008.
  51. 51.
    Hanley D: Final results of CLEAR IVH trial: clot lysis, safety, and functional outcomes [abstract]. Cerebrovasc Dis 2008, 25(Suppl 2):9.Google Scholar
  52. 52.
    Duncan PW, Zorowitz R, Bates B, et al.: Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005, 36:e100–e143.PubMedCrossRefGoogle Scholar
  53. 53.
    Pluchino S, Martino G: Neural stem cell-mediated immunomodulation: repairing the haemorrhagic brain. Brain 2008, 131:604–605.PubMedCrossRefGoogle Scholar
  54. 54.
    Lyden PD, Shuaib A, Lees KR, et al.: Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke 2007, 38:2262–2269.PubMedCrossRefGoogle Scholar
  55. 55.
    Jordan LC, Hillis AE: Hemorrhagic stroke in children. Pediat Neurol 2007, 36:73–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Divisions of Cerebrovascular Diseases and Critical Care Neurology, Department of NeurologyMayo Clinic HospitalPhoenixUSA

Personalised recommendations